NCT02598726View on ClinicalTrials.gov

Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

September 19, 2018

Study Completion Date

September 19, 2018

Conditions
Bladder SpasmMalignant NeoplasmPainUrinary Urgency
Interventions
DRUG

Curcumin

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

DIETARY_SUPPLEMENT

Piperine Extract (Standardized)

Given PO

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER